|06/10/15||The Results Are In: S+ by ResMed Users See Improvement in The Amount and Quality of Their Sleep|
|Data Shows That Among Poor Sleepers, Improved Sleep Knowledge Leads to Improved Sleep
SAN DIEGO, June 10, 2015 /PRNewswire/ -- New results from S+ by ResMed, the world's first non-contact sleep system, show that after only one week of use, more than two-thirds of users with below-average sleep scores saw significant improvement. ResMed (NYSE: RMD), the global leader in the treatment of sleep-disordered breathing and other respiratory conditions, announced that 67% of such S+ users saw impro... |
|05/13/15||ResMed Provides Update on Phase III SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy In Central Sleep Apnea and Chronic Heart Failure|
|Study Did Not Meet Primary Endpoint
Safety Signal of Increased Cardiovascular Mortality Found For ASV Therapy In People With Predominant Central Sleep Apnea and Symptomatic Chronic Heart Failure
Results and Safety Signal Observed Only In This Specific Study Population
SAN DIEGO, May 13, 2015 /PRNewswire/ -- ResMed (NYSE: RMD) today announced that SERVE-HF, a multinational, multicenter, randomized controlled Phase III trial did not meet its primary endpoint. SERVE-HF was designed to a... |
|04/30/15||ResMed Introduces Lumis Series of Noninvasive Ventilators for Personalized, Simplified and Connected Care|
|- IntelligentAir technology, a ResMed first, tailors therapy to individual breathing needs
- Built-in wireless connectivity makes for easy patient monitoring and management
SAN DIEGO, April 30, 2015 /PRNewswire/ -- ResMed (NYSE: RMD) today announced its Lumis™ series of noninvasive ventilation devices that combine personalized, simplified therapy with powerful wireless connected care capabilities. The Lumis series builds upon ResMed's legacy of innovation as a new option for patients wit... |
|04/23/15||ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015|
|Revenue increased 6% to $422 million; up 13% on a constant currency basis
GAAP diluted earnings per share of $0.64, or non-GAAP earnings per share of $0.65
Operating cash flow of $90.9 million
Company repurchased 300,000 shares in the third quarter
SAN DIEGO, April 23, 2015 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced results for its quarter ended March 31, 2015. Revenue for the quarter was $422.5 million, a 6 percent increase compared to the quarter ended March 31, 201... |
|04/02/15||ResMed To Announce Third Quarter 2015 Results|
|SAN DIEGO, April 2, 2015 /PRNewswire/ -- RESMED INC. (NYSE: RMD) today announced that it will report its third quarter of fiscal year 2015 results on Thursday, April 23, 2015, after the New York Stock Exchange market close. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook.
The earnings call is scheduled to begin at 1:30 p.m. US Pacific Time and the live webcast of the call c... |
|03/12/15||ResMed to Present New Data on Sleep-Disordered Breathing in Patients with Chronic Heart Failure at the American College of Cardiology 64th Annual Meeting|
|SAN DIEGO, March 12, 2015 /PRNewswire/ -- ResMed (NYSE: RMD) today announced data from two studies about sleep-disordered breathing (SDB) in chronic heart failure will be presented at the 64th Annual Scientific Sessions of the American College of Cardiology, from March 14th through 16th.
"The data we are presenting are important because they point toward a connection between breathing disorders in sleep, like sleep apnea, and chronic heart failure," said ResMed Chief Medical Officer, Glenn R... |
|02/12/15||ResMed Wins Continued Injunction Against BMC in German Patent Infringement Action|
|Ruling Prevents Sale of Infringing BMC Masks in Germany
MUNICH, Germany and SAN DIEGO, Calif., Feb. 12, 2015 /PRNewswire/ -- ResMed (NYSE:RMD) today announced that the Munich District Court upheld its injunction against Chinese medical device manufacturer BMC Medical Co., Ltd. (BMC). The injunction prohibits BMC from offering, selling or distributing infringing mask products in Germany.
The Munich Court's preliminary injunction decision, first rendered in November 2013, and continued in... |
|02/10/15||ResMed Acquires Jaysec, a Leader in Internet-Based Software Solutions for Home Medical Equipment Providers|
|SAN DIEGO, Feb. 10, 2015 /PRNewswire/ -- ResMed (NYSE:RMD) today announced it has acquired Jaysec, a provider of Internet-based software solutions for the home medical equipment (HME) industry. Headquartered in Knoxville, Tenn., Jaysec's products help HME providers resupply their patients and communicate with referring medical providers.
"Jaysec's products streamline key HME business practices such as resupply, allowing home medical equipment providers to focus on delivering quality care for ... |
|02/02/15||Easy-to-Use AirView™ Patient Management System by ResMed Now Integrates Directly with Brightree|
|HMEs Benefit From Powerful new Capabilities for Faster Patient On-Boarding and On-Demand Compliance Data - all in one Software Environment
SAN DIEGO and ATLANTA, Feb. 2, 2015 /PRNewswire/ -- ResMed (NYSE: RMD) and Brightree today announced ResMed's AirView patient management system will directly integrate with Brightree's leading home medical equipment (HME) billing and business management software solution.
"Since 2013, Brightree and ResMed have partnered to bring greater workflow effi... |
|01/22/15||ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015|
|Second quarter revenue increased 10% to $423 million; up 14% on a constant currency basis
Second quarter GAAP diluted earnings per share of $0.64
Second quarter operating cash flow of $106.0 million
Company repurchased 667,000 shares in the second quarter
SAN DIEGO, Jan. 22, 2015 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced results for its quarter ended December 31, 2014. Revenue for the quarter was $423.0 million, a 10 percent increase compared to the quarter ended Dece... |